(Q38019772)

27 August 2017

HIV-associated opportunistic infections of the CNS. (English)

1 reference

27 August 2017

opportunistic infection

1 reference

Ik Lin Tan

1

1 reference

27 August 2017

Bryan R Smith

2

1 reference

27 August 2017

Gloria von Geldern

3

1 reference

27 August 2017

Farrah J Mateen

4

1 reference

27 August 2017

Justin C McArthur

5

1 reference

27 August 2017

1 July 2012

1 reference

27 August 2017

1 reference

27 August 2017

11

1 reference

27 August 2017

605-617

1 reference

27 August 2017

7

1 reference

HIV-associated central nervous system diseases in the recent combination antiretroviral therapy era.

27 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

NeuroAIDS in the Asia Pacific Region.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Review of Human Immunodeficiency Virus Type 1–Related Opportunistic Infections in Sub‐Saharan Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Postmortem findings and opportunistic infections in HIV-positive patients from a public hospital in Peru

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Changing incidence of central nervous system diseases in the EuroSIDA cohort

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Survival of AIDS patients according to type of AIDS-defining event. The AIDS in Europe Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Nucleotide sequence evidence for relationship of AIDS retrovirus to lentiviruses

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Course of HIV-I infection in a cohort of homosexual and bisexual men: an 11 year follow up study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Immunopathogenic mechanisms of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Transient High Levels of Viremia in Patients with Primary Human Immunodeficiency Virus Type 1 Infection

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

HIV disease: fallout from a mucosal catastrophe?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Characterization of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte clones isolated during acute seroconversion: recognition of autologous virus sequences within a conserved immunodominant epitope

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

A Decision Guideline for Emergency Department Utilization of Noncontrast Head Computed Tomography in HIV-infected Patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Prevalence, Associated Factors, and Prognostic Determinants of AIDS‐Related Toxoplasmic Encephalitis in the Era of Advanced Highly Active Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Toxoplasma gondii infection and cerebral toxoplasmosis in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Progressive multifocal leukoencephalopathy in patients with HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Primary CNS lymphoma in HIV positive and negative patients: comparison of clinical characteristics, outcome and prognostic factors.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Induction and maintenance therapy of cytomegalovirus central nervous system infection in HIV-infected patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Cytomegalovirus encephalitis in acquired immunodeficiency syndrome (AIDS).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. The NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

The role of cryptococcal antigen assay in diagnosis and monitoring of cryptococcal meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Timing of initiation of antiretroviral therapy in human immunodeficiency virus (HIV)--associated tuberculous meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

The clinical, radiological and pathological profile of tuberculous meningitis in patients with and without human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

The influence of HIV infection on clinical presentation, response to treatment, and outcome in adults with Tuberculous meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Diagnosis of AIDS-related focal brain lesions: a decision-making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays in CSF.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Evaluation and management of intracranial mass lesions in AIDS. Report of the Quality Standards Subcommittee of the American Academy of Neurology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

HIV-associated primary CNS lymorbidity and utility of brain biopsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

HIV and Tuberculosis: a Deadly Human Syndemic

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Pretreatment intracerebral and peripheral blood immune responses in Vietnamese adults with tuberculous meningitis: diagnostic value and relationship to disease severity and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Tuberculous meningitis: a uniform case definition for use in clinical research

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Comparison of conventional bacteriology with nucleic acid amplification (amplified mycobacterium direct test) for diagnosis of tuberculous meningitis before and after inception of antituberculosis chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Role of interferon gamma release assay in active TB diagnosis among HIV infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Clinical and microbiological features of HIV-associated tuberculous meningitis in Vietnamese adults

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Multidrug-resistant tuberculous meningitis in KwaZulu-Natal, South Africa.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Cerebral Toxoplasmosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

A prospective study of criteria for the diagnosis of toxoplasmic encephalitis in 186 AIDS patients. The BIOTOXO Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

PCR detection of Toxoplasma gondii DNA in CSF for the differential diagnosis of AIDS-related focal brain lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Molecular diagnosis of Toxoplasma gondii infection in cerebrospinal fluid from AIDS patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Neurotoxoplasmosis diagnosis for HIV-1 patients by real-time PCR of cerebrospinal fluid.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Immunodiagnosis in cerebrospinal fluid of cerebral toxoplasmosis and HIV-infected patients using Toxoplasma gondii excreted/secreted antigens

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Evaluating contrast-enhancing brain lesions in patients with AIDS by using positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

SPECT thallium-201 combined with Toxoplasma serology for the presumptive diagnosis of focal central nervous system mass lesions in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Management of toxoplasmic encephalitis in HIV-infected adults (with an emphasis on resource-poor settings)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Toxoplasmic encephalitis in an AIDS cohort at Puerto Rico before and after highly active antiretroviral therapy (HAART)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Cryptococcal meningitis: current approaches to management in patients with and without AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Cerebrospinal fluid profiles in acquired immunodeficiency syndrome with and without neurocryptococcosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Diagnosis of cryptococcal and tuberculous meningitis in a resource-limited African setting

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma, and urine from patients with HIV-associated cryptococcal meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Nationwide population-based epidemiologic study of cryptococcal meningitis in Taiwan.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Large volume lumbar punctures in cryptococcal meningitis clear cryptococcal antigen as well as lowering pressure

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Lumbar drainage for control of raised cerebrospinal fluid pressure in cryptococcal meningitis: case report and review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Comparison of 2 doses of liposomal amphotericin B and conventional amphotericin B deoxycholate for treatment of AIDS-associated acute cryptococcal meningitis: a randomized, double-blind clinical trial of efficacy and safety

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Primary prophylaxis of cryptococcal disease with fluconazole in HIV-positive Ugandan adults: a double-blind, randomised, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Differing spectrum of HIV-associated ophthalmic disease among patients starting antiretroviral therapy in India and South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Neuroimaging of pediatric central nervous system cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Predominance of neutrophils in the cerebrospinal fluid of AIDS patients with cytomegalovirus radiculopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Impairment of short-term memory and Korsakoff syndrome are common in AIDS patients with cytomegalovirus encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Cytomegalovirus retinitis in patients with acquired immune deficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Antiviral drugs for cytomegalovirus diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Antiviral drugs for viruses other than human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Evaluation of the United States public health service guidelines for discontinuation of anticytomegalovirus therapy after immune recovery in patients with cytomegalovirus retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Mass spectrometry-based comparative sequencing to detect ganciclovir resistance in the UL97 gene of human cytomegalovirus.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Progressive multifocal leukoencephalopathy in an HIV patient receiving successful long-term HAART

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Fatal inflammatory AIDS-associated PML with high CD4 counts on HAART: a new clinical entity?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Prevalence of Antibodies in Human Sera against JC Virus, an Isolate from a Case of Progressive Multifocal Leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Polyomavirus JCV excretion and genotype analysis in HIV-infected patients receiving highly active antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

The basis for modeling progressive multifocal leukoencephalopathy pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Involvement of JC virus-infected mononuclear cells from the bone marrow and spleen in the pathogenesis of progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Presence and expression of JCV early gene large T Antigen in the brains of immunocompromised and immunocompetent individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Adaptive mutations in the JC virus protein capsid are associated with progressive multifocal leukoencephalopathy (PML)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Archetypal and rearranged sequences of human polyomavirus JC transcription control region in peripheral blood leukocytes and in cerebrospinal fluid.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Identical rearranged forms of JC polyomavirus transcriptional control region in plasma and cerebrospinal fluid of acquired immunodeficiency syndrome patients with progressive multifocal leukoencephalopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

JC virus agnoprotein inhibits in vitro differentiation of oligodendrocytes and promotes apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Traffic of JC virus from sites of initial infection to the brain: the path to progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

JC virus granule cell neuronopathy: A novel clinical syndrome distinct from progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Fulminant JC virus encephalopathy with productive infection of cortical pyramidal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Trans-activation of the JC virus late promoter by the tat protein of type 1 human immunodeficiency virus in glial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Differential diagnosis of stroke in a setting of high HIV prevalence in Blantyre, Malawi.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

PML-IRIS in patients with HIV infection: clinical manifestations and treatment with steroids

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Possible JCV granular cell neuronopathy in a patient with HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Polymerase chain reaction for detection of JC virus DNA in cerebrospinal fluid: a quality control study. European Union Concerted Action on Viral Meningitis and Encephalitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Analysis of PCR as a tool for detection of JC virus DNA in cerebrospinal fluid for diagnosis of progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Improved survival of HIV-1-infected patients with progressive multifocal leukoencephalopathy receiving early 5-drug combination antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Determinants of survival in progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: data from the Italian Registry Investigative Neuro AIDS (IRINA).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Association of prolonged survival in HLA-A2+ progressive multifocal leukoencephalopathy patients with a CTL response specific for a commonly recognized JC virus epitope.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Survival prolongation in HIV-associated progressive multifocal leukoencephalopathy treated with alpha-interferon: an observational study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Clinical and virological monitoring during treatment with intrathecal cytarabine in patients with AIDS-associated progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Mirtazapine use in human immunodeficiency virus-infected patients with progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Hexadecyloxypropyl-cidofovir (CMX001) suppresses JC virus replication in human fetal brain SVG cell cultures

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Primary central nervous system lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Highly active antiretroviral therapy and human immunodeficiency virus-associated primary cerebral lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Proportions of Kaposi sarcoma, selected non-Hodgkin lymphomas, and cervical cancer in the United States occurring in persons with AIDS, 1980-2007.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Primary diffuse large B-cell lymphomas of the central nervous system are targeted by aberrant somatic hypermutation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Modern concepts in the biology, diagnosis, differential diagnosis and treatment of primary central nervous system lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Predictive value of polymerase chain reaction of cerebrospinal fluid for detection of Epstein-Barr virus to establish the diagnosis of HIV-related primary central nervous system lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

The predictive value of cerebrospinal fluid Epstein-Barr viral load as a marker of primary central nervous system lymphoma in HIV-infected persons

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Human immunodeficiency virus-related lymphoma. Prognostic factors predictive of survival.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Treatment patterns and prognosis in patients with human immunodeficiency virus and primary central system lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Human immunodeficiency virus-related primary central nervous system lymphoma: factors influencing survival in 111 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Herpes simplex virus infections of the central nervous system in human immunodeficiency virus-infected patients: clinical management by polymerase chain reaction assay of cerebrospinal fluid.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Herpes simplex virus infection of the central nervous system in human immunodeficiency virus-type 1-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Evaluation of the range of clinical presentations of herpes simplex encephalitis by using polymerase chain reaction assay of cerebrospinal fluid samples.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2812%2970098-4

7 January 2021

10.1016/S1474-4422(12)70098-4

Identifiers

DOI

1 reference

27 August 2017

1 reference